The trial was able to elicit more than double the microdystrophin gene in patients after 90 days of treatment.

DMD Systems Recovery, LLC (DMD) proudly announces its recognition on the 2025 MO 100 Top Impact CEO Ranking for the third consecutive year, reinforcing its commitment to sustainable and responsible ...

Medically reviewed by Smita Patel, DO Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed ...

The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, ...

Solid Biosciences has surged back into the Duchenne muscular dystrophy (DMD) gene therapy race. | Solid Biosciences has ...

Although the Pennsylvania Center for Dental Implants & Periodontics has been serving the Philadelphia region for more than 35 ...

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

Solid Biosciences’ gene therapy uses a shortened version of the dystrophin protein, which is engineered to mimic the key ...

Dr. Ritu Manchanda earned her B.D.S. from Bharti Vidyapeeth Dental College, Pune, India. She then received her D.M.D. from ...